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Background: Although nephron-sparing surgery has been reported not to affect total renal function, it is a
non-negligible fact that functional damage of the operated kidney usually results, for various reasons. This study
aimed to explore the effects of preoperative baseline characteristics, tumor characteristics, and function protection
methods on postoperative renal damage.
Methods: This study was a retrospective review of 51 patients who underwent open nephron-sparing surgery.
The mean age of the patients (39 men, 12 women) was 54.2 ± 13.9 years, range 32 to 71 years. The glomerular
filtration rate (GFR) was measured preoperatively and 6th months after the operation. Univariate analysis was used
to screen indicators with significant differences in different levels of renal function damage. All variables found to
be significant on univariate analysis were entered into a multiple logistic regression model to predict risk factors
for renal function damage.
Results: Univariate analysis showed that there was a significant difference in age, GFR of operated kidney, tumor
diameter, tumor depth, and ischemic protection type between patients with little damage and those with heavy
damage (P < 0.05). Forward stepwise logistic regression analysis suggested that age (odds ratio, 3.08; 95% confidence
interval 1.78 to 7.04; P = 0.037), preoperative GFR of operated kidney (odds ratio, 0.51; 95% confidence interval 0.11 to
0.73; P = 0.033), and tumor diameter (odds ratio, 5.49; 95% confidence interval 2.14 to 7.88; P = 0.012) and depth (odds
ratio, 5.82; 95% confidence interval 2.66 to 8.06; P = 0.010) were independent risk factors for postoperative renal
function damage.
Conclusions: Patients with older age, poor renal function, and large tumor diameter and depth might be at higher risk
of renal function damage after nephron-sparing surgery.
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Renal cell carcinoma, which accounts for 2% of solid tu-
mors, is the most common urologic malignant tumor. It is
estimated that renal cell carcinoma affects more than
40,000 patients annually in the United States and is re-
sponsible for approximately 13,000 deaths [1]. Radical
nephrectomy has long been considered the most effective
option for surgeons in the management of renal cell car-
cinoma. However, renal functional loss after radical neph-
rectomy contributes to the development of chronic kidney
disease in the majority of patients, which is a significant
risk factor for cardiovascular events and death [2].* Correspondence: jasonqi@sh163.net
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reproduction in any medium, provided the orRecently, nephron-sparing surgery has been the subject
of much attention. Several clinical studies have already in-
dicated that nephron-sparing surgery ensures favorable
oncological results for tumors smaller than 4 cm com-
pared with radical nephrectomy, in addition to preserving
renal function [3-7]. Because of these beneficial outcomes,
there has been an increase in the use of nephron-sparing
surgery. At major urological institutions, nephron-sparing
surgery is even largely used for tumors up to 7 cm in
diameter, to extend elective indications [8-12]. However, it
has been reported that nephron-sparing surgery impairs
the function of the operated kidney because of temporary
renal blood flow blockage for reduction of bleeding and
loss of normal renal parenchyma around the tumor during
resection and suture [13]. Therefore, assessing predictorsThis is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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ing nephron-sparing surgery to prevent it is still crucial
for patients’ survival [14]. The aim of this study was to
investigate preoperative indicators that might predict




A total of 51 patients (approved by Xinhua Hospital,
School of Medicine, Shanghai JiaoTong University eth-
ics committee) who underwent open nephron-sparing
surgery for a kidney tumor, as diagnosed by ultrasonog-
raphy, computed tomography, or magnetic resonance
imaging, were enrolled in this study between Jan 2009
and Dec 2011. The mean age of the patients (39 men,
12 women) was 54.2 ± 13.9 years, range 32 to 71 years. Pa-
tients with single kidneys were excluded from the study.
Preoperative renal function was normal in all the patients.
The patients’ blood levels of serum creatinine and urea ni-
trogen were 89 ± 20.1 μmol/l (range 78.5 to 109 μmol/l)
and 5.7 ± 3.3 mmol/l (range 4.9 to 9.4 mmol/l), respect-
ively. Preoperative backache was found in three cases;
there was no gross hematuria or abdominal mass. All the
tumors involved were unilateral (28 tumors on the left
and 23 on the right kidney). According to the preoperative
findings evaluated by computed tomography or magnetic
resonance imaging, tumors were divided into large (diam-
eter > 4 cm, 15 cases), medium (1 cm < diameter ≤ 4 cm,
28 cases) and small (diameter ≤ 1 cm, 8 cases) by their
size. The tumors were also divided into exophytic (> 50%
of the tumor circumference outside of renal parenchyma,
12 cases), central (≈ 50% of the tumor circumference out-
side of renal parenchyma, 26 cases) and intraparenchymal
(< 50% of the tumor circumference outside of renal paren-
chyma, 13 cases) according to the depth of the tumor.
Surgical technique
The patients were placed in a lateral decubitus position on
the unaffected side and given general anesthesia. Using an
extraperitoneal flank incision through the 12th rib, the
renal pedicle was dissected free between the perirenal
fascia and the major psoas muscle to allow for clamping
by different vessel blockage types. Selective clamping of
the artery, or blocking artery and vein, followed, depend-
ing on the distribution of the renal pedicle and the morph-
ology and location of the renal mass [15]. Routinely, the
renal artery was dissected free and clamped using a Rumel
tourniquet (continuous artery blocking in 32 patients).
Where patients had obvious tumor adhesions to the renal
pedicle or larger tumor size, the renal pedicle, including
the renal artery and renal vein, were clamped with a
Rumel tourniquet (19 patients) to avoid vascular injury
when isolating the renal artery. Owing to the difference inthe personal habits of operators, different ischemic protec-
tion types were also used for operative warm ischemia of
the kidney, including local cooling (30 patients), where
sterile ice slush was placed around the kidney following
vascular occlusion, and mannitol application (21 patients),
where 250 ml 20% mannitol solution was given intraven-
ously and rapidly 5 min before vessel occlusion. The
perirenal fascia was opened immediately after the occlu-
sion of blood vessels. The tumor was located after dissoci-
ation of the adipose capsule and should have been
completely resected, leaving a 5 to 10 mm margin of nor-
mal renal parenchyma around the tumor. If there was
damage to the collection system, it was oversewn with
3–0 absorbable sutures. The wound was closed in layers
with 2–0 absorbable sutures in a figure-of-eight fashion.
The vascular occlusion time should be less than 30 min
before blood flow recovery. Drainage of retroperitoneal
space was performed for 24 to 48 h and the incision was
closed routinely. Patients were placed in a horizontal pos-
ition postoperatively for 72 h.
Assessment of renal function
Glomerular filtration rate (GFR) was measured using
99mTc-diethylenetriamine pentaacetic acid dynamic renal
scintigraphy preoperatively and at the postoperative 6th
month. The level of renal function damage was divided
into ‘no damage’ (ΔGFR ≤ 10 ml/min 1.73 m2), ‘slight’
(10 ml/min 1.73 m2 < ΔGFR ≤ 20 ml/min 1.73 m2), ‘mod-
erate’ (20 ml/min 1.73 m2 < ΔGFR ≤ 30 ml/min 1.73 m2),
and ‘serious’ (ΔGFR > 30 ml/min 1.73 m2), according to
the difference between preoperative and postoperative
GFR (ΔGFR) of tumor-involved kidney. The levels of no
and slight renal function damage were further combined
into ‘little’, and the levels of moderate and serious renal
function damage were combined into ‘heavy’.
Statistical analysis
One-way analysis of variance (ANOVA, for continuous
variables) or chi-square test (for categorical variables)
were used to filter indicators with significant differences
in each level of renal function according to preoperative
baseline characteristics (age and sex), tumor characteris-
tics (location, maximum diameter, depth, and pathology)
and function protection types (vessel blockage type,
warm ischemic time, and ischemic protection type). All
variables significant on univariate analysis were entered
into a multiple logistic regression model to predict the
risk factors for renal function damage (‘little’ or ‘heavy’).
Statistical analyses were performed using SPSS 19.0 soft-
ware. P < 0.05 was considered statistically significant.
Results
Preoperative baseline characteristics are detailed in Table 1.
All the patients successfully completed the surgery, and












Diameter (mean ± standard deviation, cm) 3.1 ± 1.8
Maximum diameter (n)
Φ ≤ 1 cm 8
1 cm < Φ ≤ 4 cm 28
Φ > 4 cm 15
Depth (n)
Exophytic (> 50% of the tumor circumference
outside of renal parenchyma)
12
Central (≈ 50% of the tumor circumference
outside of renal parenchyma)
26
Intraparenchymal (< 50% of the tumor
circumference outside of renal parenchyma)
13
GFR of tumor-involved kidney





Table 3 Function damage level according to ΔGFR in 51
patients
Level of function damage (n) Value
Little
None 17
(ΔGFR ≤ 10 ml/min 1.73 m2)
Slight 19
(10 ml/min 1.73 m2 < ΔGFR ≤ 20 ml/min 1.73 m2)
Heavy
Moderate 9
(20 ml/min 1.73 m2 < ΔGFR ≤ 30 ml/min 1.73 m2)
Serious 6
(ΔGFR > 30 ml/min 1.73 m2)
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renal function in surgery are shown in Table 2. Compared
with preoperative GFR levels of the tumor-involved kid-
ney, we found no, slight, moderate, and serious damage of
renal function in 17, 19, 9, and 6 patients at the postopera-
tive 6th month, respectively (Table 3). Univariate analysisTable 2 Protection types of renal function in surgery
Parameter Value
Vessel blockage type (n)
Continuous artery blocking 32
Continuous artery and vein blocking 19
Ischemic protection type (n)
Local cooling 30
Mannitol application 21
Warm ischemic time (n)
≤ 25 minutes 40
> 25 minutes 11indicated that there was a significant difference in age,
preoperative GFR of tumor-involved kidney, tumor diam-
eter, tumor depth, or ischemic protection type between
different renal function damage groups (P < 0.05, Table 4).
Forward stepwise logistic regression analysis suggested
that age, preoperative GFR of tumor-involved kidney,
tumor diameter and depth were independent predictors of
postoperative renal function damage (P < 0.05, Table 5).
Discussion
The GFR is considered the best parameter for assessing
renal function because it is directly proportional to the
number of functioning nephrons [16]. In this study, we
also assessed kidney function changes preoperatively and
postoperatively by measuring GFR with 99mTc-diethyle-
netriamine pentaacetic acid renal scintigraphy [17]. In the
normal population, an irreversible decline of renal func-
tion occurs with aging, showing reduced GFR levels [18].
These changes are minor, but tend to be more obvious
when the kidney suffers a trauma. Tolerance to surgery is
poor if the kidney has preoperative dysfunction, and post-
operative damage of kidney is often serious [19]. These
were also confirmed in our study; preoperative GFR of
tumor-involved kidney and age of patients were independ-
ent predictors of postoperative renal function damage.
Given the validity of GFR for assessing renal function,
we divided patients into those with little and heavy dam-
age, according to GFR changes, which we used to explore
risk factors for renal function damage by comparing pre-
operative baseline characteristics, tumor characteristics,
and function protection methods between two groups.
The results indicated that tumor diameter, tumor depth,
or ischemic protection methods were independent predic-
tors of postoperative renal function damage.
Tumor size is the key factor in determining surgical pro-
cedures. Generally, nephron-sparing surgery is considered
the optimum treatment for tumors smaller than 4 cm in
diameter [20], and nephron-sparing surgery can be offered
Table 4 Univariate analysis of baseline characteristics, tumor characteristics, and function protection types in each
level of renal function





Age (mean ± SD) 50.4 ± 6.9 56.4 ± 8.0 0.042**






GFR of tumor-involved kidney (ml/min 1.73 m2) 48.1 ± 8.8 41.5 ± 9.7 0.039**
Tumor characteristics
Maximum diameter (n) 0.047*
Φ ≤ 1 cm 7 1
1 cm < Φ ≤ 4 cm 22 6






Vessel blockage type (n) 0.794*
Continuous artery blocking 23 9
Continuous artery and vein blocking 13 6
Ischemic protection type (n) 0.017*
Local cooling 25 5
Mannitol application 11 10
Warm ischemic time 0.187*
≤25 minutes 30 10
>25 minutes 6 5
*Chi-square test, ** ANOVA. Italic p values indicate statistical significance.
Table 5 Forward stepwise logistic regression analysis of





Age (years) 3.08 (1.78-7.04) 0.037
Baseline GFR (ml/min•1.73 m2) 0.51 (0.11-0.73) 0.033
Maximum diameter (cm) 5.49 (2.14-7.88) 0.012
Tumor depth (tumor position relative
to the renal parenchyma)
5.82 (2.66-8.06) 0.010
Local cooling application 0.78 (0.58-1.51) 0.061
Italic P values indicate statistical significance.
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difficult [21]. When the tumor is larger than 7 cm in
diameter, radical nephrectomy should be chosen because
satellite nodules could exist in the periphery of the tumor,
and lead to a high postoperative local recurrence rate [22].
In this study, 15 patients had tumors larger than 4 cm in
diameter, and the maximum diameter was 4.8 cm. Our re-
sults showed that the risk of renal function damage after
the operation increased as the tumor diameter increased.
This may be because resection of a larger tumor volume
requires a longer vascular occlusion time and causes a re-
duced residual normal renal parenchyma.
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gin of normal-appearing parenchyma is a standard tech-
nique during nephron-sparing surgery, to avoid local
recurrence [23]. However, margins of 10 mm may not be
desirable, as they may result in the resection of tumors
close to the renal hilum and result in increasing injury
to the urinary collecting system and hilar vessels [24].
Thus, a peritumoral margin smaller than 10 mm is advo-
cated (0.5 to 1.0 cm in our study) [25]. This kind of mar-
gin is easily achievable for exophytic tumors but not
intraparenchymal or juxtahilar tumors, in which adja-
cent vascular structures or collecting systems are located
[26]. In practice, there may be some deviations in the
peritumoral margin (possible larger than 1 cm) after ad-
vancing the renal parenchyma at the marked margin for
patients with intraparenchymal tumors, leading to renal
damage. Our results also demonstrated this conclusion
that patients with a deeper tumor location had a high
risk of postoperative renal function damage, although
local recurrence was not found in all follow-up patients.
Recent clinical studies demonstrated that warm ische-
mia should be within 20 to 25 min. When the warm is-
chemic time is ≥ 25 minutes, irreversible diffuse damage
may be seen in surgically preserved nephrons [13,27,28].
Moreover, some scholars suggest zero ischemia partial
nephrectomy only with preoperative superselective arter-
ial embolization [29-33]. However, our results indicated
there was no significant difference in ischemic time be-
tween different renal function damage groups. This may
be associated with abundant collateral circulation from
the adrenal and capsular branches, which leads to en-
hanced tolerance to ischemia [34].
Renal dysfunction is also related to the method of occ-
lusion. Local cooling is the best way to protect renal
function if the expected warm ischemic time exceeds
30 minutes [35]. Renal hypothermia in the range of 5 to
15°C is considered optimal for renal protection, based on
the classic Ward experiment [36]. Nevertheless, it is diffi-
cult to fall to this standard as the kidney is exposed in the
surgical field. For clinical practicability, a temperature of 20
to 25°C appears to provide complete renal protection for
up to 3 h of arterial occlusion [37,38]. Univariate analysis
of our results showed that local cooling benefited the renal
function; however, multivariate analysis found no signifi-
cant difference. This may be due to the short vascular oc-
clusion time in our study, with a maximum time of 38 min.
Conclusions
It is necessary to assess the preoperative risk and degree
of renal function damage in order to protect residual
renal function after nephron-sparing surgery. For pa-
tients with preoperative high-risk factors such as older
age, poor preoperative renal function, large tumor size,
or deep tumor location, such precautions as vascularocclusion and ischemia protection should be taken.
Monitoring of patients with high-risk factors should be
performed, to minimize renal function damage after
nephron-sparing surgery.
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